Table 2. Changes in Iqgap Gene/mRNA Expression Level in Neoplasms‡.
Tissue Comparison | IQGAP | Species | Method | Neoplasm | Expression Change | Refs |
---|---|---|---|---|---|---|
Cancer vs Normal | Iqgap1 | Human | Array | Colorectal | + | [73] |
Glioma | + | [97] | ||||
RT-PCR | Glioma | + | [97] | |||
Lung | + | [72] | ||||
Mouse | Array | Prostate | + | [74] | ||
Iqgap2 | Human | Array | Colorectal | + | [78] | |
Prostate | + | [79] | ||||
Aggressive vs Less Aggressive Cancer† | Iqgap1 | Human | Array | Glioma | + | [88]a |
Mouse | Array | Medulloblastoma | + | [98]b | ||
Melanoma | + | [90]c | ||||
Iqgap2 | Human | Array | Prostate | - | [77]d | |
Mouse | Array | Prostate | - | [74]e | ||
Iqgap3 | Human | Array | Colorectal | - | [99]f |
increased expression;
decreased expression.
Aggressive vs less aggressive cancer is defined by a decrease in long-term survivala,f, an increase in the likelihood of metastasisb,c,e or a decline in tumor responsiveness to hormone therapyd.
Only published studies with primary tissue are included. Data with cultured cell lines have been omitted.